Posted:
9/10/2025, 7:58:58 PM
Location(s):
Karlsruhe, Baden-Württemberg, Germany ⋅ Baden-Württemberg, Germany
Experience Level(s):
Senior
Field(s):
Product
Workplace Type:
Remote
Position Overview:
The Senior Commercial Manager is responsible for establishing, managing and maintaining Commercial Models that govern the Order to Cash process for the Omnipod portfolio of products in select European countries where Insulet has direct operations, including but not limited to the German, Austrian and Swiss markets. In this capacity, the role supervises key commercial relationships and agreements for the Omnipod Insulin Management System in the specified markers across relevant stakeholders, including Hospital Trusts, Integrated Careboarss, and Framework Agreements. Insulet strive to be seen as a market leader and preferred partner to our commercial customers, and be proactive and diligent in all aspects of doing business with these critical stakeholders. Importantly, this includes understanding the terms and conditions of doing business under each of our agreements, such as NHS and Belgium tenders, and proactively following up and meeting our obligations as a supplier, communicating actively with each stakeholder. The role is also instrumental in delivering product launches in ensuring that there is unhindered access to new products while achieving exact timelines and other commercial ambitions, such as business model changes and/or revisions to the pricing methodology and procurement processes.
This role is a part of the DACH team and report to the General Manager, DACH.
Responsibilities
Required Leadership/Interpersonal Skills & Behaviors
Required Skills and Competencies
Education and Experience
Additional Information
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by a compatible personal smartphone in the U.S. or by the Omnipod 5 Controller. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit insulet.com and omnipod.com.
We are looking for highly motivated, performance-driven individuals to be a part of our expanding team. We do this by hiring amazing people guided by shared values who exceed customer expectations. Our continued success depends on it!
Please read our Privacy Notice to learn how Insulet handles your personal information when you apply for a vacancy with us here.
Website: https://insulet.com/
Headquarter Location: Bedford, Massachusetts, United States
Employee Count: 501-1000
Year Founded: 2000
IPO Status: Private
Last Funding Type: Post-IPO Debt
Industries: Biotechnology ⋅ Diabetes ⋅ Health Care ⋅ Medical Device